MUR
36
3
NWSA
64
-15
CFG
95
2
MPC
38
2
TMO
60
4
ZTS
21
2
HAL
50
2
CA
30
3
VTR
67
-3
DTE
38
-4
BAC
77
5
TEL
66
6
AIV
37
-2
CMA
70
5
GIS
58
-2
EQIX
64
5
TDC
70
3
SWKS
55
2
APH
56
7
ABBV
59
13
MUR
36
3
NWSA
64
-15
CFG
95
2
MPC
38
2
TMO
60
4
ZTS
21
2
HAL
50
2
CA
30
3
VTR
67
-3
DTE
38
-4
BAC
77
5
TEL
66
6
AIV
37
-2
CMA
70
5
GIS
58
-2
EQIX
64
5
TDC
70
3
SWKS
55
2
APH
56
7
ABBV
59
13
Financhill
Back

4D Molecular Therapeutics, Inc. Vs. Tonix Pharmaceuticals Holding Corp. Industry Stock Comparison

Sell
27

FDMT
4D Molecular Therapeutics, Inc.

Last Price:
$8.67
Seasonality Move:
0.56%
Sell
29

TNXP
Tonix Pharmaceuticals Holding Corp.

Last Price:
$17.13
Seasonality Move:
2.21%
Sell
27
4D Molecular Therapeutics, Inc. (FDMT) is a Sell

Is 4D Molecular Therapeutics, Inc. a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics, Inc. [FDMT] share price is $8.68. The Score for FDMT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Tonix Pharmaceuticals Holding Corp. (TNXP) is a Sell

Is Tonix Pharmaceuticals Holding Corp. a Buy, Sell or Hold?

  • The current Tonix Pharmaceuticals Holding Corp. [TNXP] share price is $17.09. The Score for TNXP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • TNXP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics, Inc.'s stock price today?

  • The 4D Molecular Therapeutics, Inc. share price today is $8.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight selling pressure.

TNXP Stock Price Chart

What is Tonix Pharmaceuticals Holding Corp.'s stock price today?

  • The Tonix Pharmaceuticals Holding Corp. share price today is $17.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNXP is experiencing selling pressure, which indicates risk of future bearish movement.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 37.01 Sell
Chaikin Money Flow: -360388 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.85 - 11.31) Sell
Bollinger Bands (100): (6.83 - 10.87) Sell

TNXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.32 Buy
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: -934278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.5 - 19.18) Sell
Bollinger Bands (100): (14.97 - 36.13) Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.21 Sell
20-day SMA: 10.58 Sell
50-day SMA: 10.64 Sell
200-day SMA: 6.3 Buy
8-day EMA: 9.84 Sell
20-day EMA: 10.33 Sell
50-day EMA: 10.1 Sell
200-day EMA: 8.25 Buy

TNXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.68 Sell
20-day SMA: 17.61 Sell
50-day SMA: 18.01 Sell
200-day SMA: 26.98 Sell
8-day EMA: 9.36 Buy
20-day EMA: 4.6 Buy
50-day EMA: 2.01 Buy
200-day EMA: 0.52 Buy

4D Molecular Therapeutics, Inc. Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.

Tonix Pharmaceuticals Holding Corp. Earnings Growth & TNXP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.85 per share, a decrease next quarter of $0.00 per share, a decrease this year of $9.86 per share, and an increase next year of $4.76 per share.

4D Molecular Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Tonix Pharmaceuticals Holding Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):